XML 59 R49.htm IDEA: XBRL DOCUMENT v3.23.3
LICENSING AGREEMENTS AND ACQUISITIONS - Pro Forma Information (Details) - XIIDRA® And Certain Other Ophthalmology Assets Acquisition - Bausch + Lomb - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Business Acquisition [Line Items]        
Revenues $ 2,302 $ 2,155 $ 6,598 $ 6,273
Net (loss) income (466) 355 (783) (42)
Net (loss) income attributable to Bausch Health Companies Inc. $ (448) $ 332 $ (732) $ (49)